Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2026-03-19 @ 12:51 PM
Study NCT ID:
NCT00441103
Status:
COMPLETED
Last Update Posted:
2014-07-09
First Post:
2007-02-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization: